ASX:NXS Next Science (NXS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Next Science Stock (ASX:NXS) Get Next Science alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume86,564 shsAverage VolumeN/AMarket CapitalizationA$22.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Next Science Limited engages in the research, development, and commercialization of technologies that address the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial gel that conforms to the postoperative wound; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, including microorganisms from wounds. The company was founded in 2012 and is headquartered in Sydney, Australia. Read More Receive NXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Next Science and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NXS Stock News HeadlinesNext Science Completes Major Asset Sale to OSARTISSeptember 15, 2025 | tipranks.comNext Science First Half 2025 Earnings: US$0.016 loss per share (vs US$0.02 loss in 1H 2024)September 2, 2025 | finance.yahoo.comMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.September 20 at 2:00 AM | American Alternative (Ad)Next Science Reports Revenue Decline but Reduces Losses in H1 2025August 28, 2025 | tipranks.comNext Science Reports Decline in Sales and Asset Sale ApprovalAugust 28, 2025 | tipranks.comNext Science Limited Announces Successful Resolution at General MeetingAugust 28, 2025 | tipranks.comNext Science Ltd Updates Director’s ShareholdingJuly 14, 2025 | tipranks.comHealth Check: Like bloodthirsty sharks, offshore acquirers are circling cheap biotech assetsJuly 2, 2025 | msn.comSee More Headlines NXS Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Next Science own? Based on aggregate information from My MarketBeat watchlists, some other companies that Next Science investors own include Abbott Laboratories (ABT), iShares ESG Aware MSCI EM ETF (ESGE), AbbVie (ABBV), Goldman Sachs Physical Gold ETF (AAAU), Argo Investments (ARG), Arcturus Therapeutics (ARCT) and Appen (APX). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:NXS CIKN/A Webwww.nextscience.com Phone61 2 8607 5124FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$13.50 million Net Margins-58.05% Pretax MarginN/A Return on Equity-139.08% Return on Assets-71.39% Debt Debt-to-Equity Ratio11.67 Current Ratio2.17 Quick Ratio4.80 Sales & Book Value Annual SalesA$23.31 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow17.23 Book ValueA$0.02 per share Price / BookN/AMiscellaneous Outstanding Shares292,160,000Free FloatN/AMarket CapA$22.99 million OptionableNot Optionable Beta1.43 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (ASX:NXS) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Next Science Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Next Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NXS Stock Alerts